July 2019 | AIChE

You are here

July 2019

Onsite Information

Venue Floor Plans Onsite Registration Hours Transportation Shipping & Printing in Orlando WIC Accommodations Room / Mothers Room Daycare Services Special Offer from Universal Studios, Orlando Recording & Photography Policy Code of Conduct Venue Floor Plans Need help finding your way between...

Process Safety Leadership from the Boardroom to the Frontline

May, 2019
This book discusses how leaders apply these attributes to drive strong process safety cultures and disciplined management systems.

Noah Helman

Noah Helman, Ph.D., is a co-founder of Industrial Microbes, a Bay Area synthetic biology startup focused on developing a flexible chemical-manufacturing platform using methane as the raw material.   He received his A.B. degree in physics from Harvard University and a Ph.D. in applied physics from Stanford University.  He transitioned into the field of synthetic biology as a postdoctoral fellow in the Department of Cellular and Molecular Pharmacology at UC San Francisco.  He began his career in industrial biotechnology at LS9 where he developed a directed evolution...Read more

Noah Helman

Noah Helman, Ph.D., is a co-founder of Industrial Microbes, a Bay Area synthetic biology startup focused on developing a flexible chemical-manufacturing platform using methane as the raw material.   He received his A.B. degree in physics from Harvard University and a Ph.D. in applied physics from Stanford University.  He transitioned into the field of synthetic biology as a postdoctoral fellow in the Department of Cellular and Molecular Pharmacology at UC San Francisco.  He began his career in industrial biotechnology at LS9 where he developed a directed evolution...Read more

Samuel Rabkin

Samuel Rabkin is the Thomas A. Pappas Professor in Neurosciences and Professor of Neurosurgery (Microbiology) at Harvard Medical School, Boston MA, and Virologist in Neurosurgery in the Brain Tumor Research Center at Massachusetts General Hospital, Boston.  Dr. Rabkin's lab has focused on the development of oncolytic herpes simplex virus (oHSV) for cancer therapy, including the first oHSV to enter clinical trial in the US and oHSV immunovirotherapy strategies and combinations for glioblastoma.  ...Read more

This Week in Chemical Engineering - Fuels & Petrochemicals Spotlight: July 15, 2019

Don't miss out on the latest business and technology news for chemical engineers, featuring select items in relation to Fuels and Petrochemicals!

This Week in Chemical Engineering - Food, Pharmaceutical & Bioengineering Spotlight: July 15, 2019

Don't miss out on the latest business and technology news for chemical engineers, featuring select items in relation to Food, Pharmaceuticals & Bioengineering!

Pages